AGP Picks
View all

Yemen Health Report
Provided by AGP

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 1, 2026

University of Miami Miller School of Medicine Names Dr. Pradeep Ramulu Chair of Ophthalmology and the Bascom Palmer Eye Institute
39 minutes ago

University of Miami Miller School of Medicine Names Dr. Pradeep Ramulu Chair of Ophthalmology and the Bascom Palmer Eye Institute

Indeterminate GlobeNewswire
Teva to Present at the Goldman Sachs Global Healthcare Conference
an hour ago

Teva to Present at the Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
an hour ago

CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair

Indeterminate GlobeNewswire
Praxis Precision Medicines Provides Vormatrigine Program Update
an hour ago

Praxis Precision Medicines Provides Vormatrigine Program Update

Indeterminate GlobeNewswire
UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
an hour ago

UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
an hour ago

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Indeterminate GlobeNewswire
Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère
an hour ago

Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

Indeterminate GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
an hour ago

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Indeterminate GlobeNewswire
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
an hour ago

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

Indeterminate GlobeNewswire
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
an hour ago

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
an hour ago

Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference
an hour ago

Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
an hour ago

Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q

Indeterminate GlobeNewswire
Fourfront Contributor launches ‘Return on Response’ campaign to highlight value of behavioral health and law enforcement crisis response partnerships
2 hours ago

Fourfront Contributor launches ‘Return on Response’ campaign to highlight value of behavioral health and law enforcement crisis response partnerships

Indeterminate GlobeNewswire
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact 
2 hours ago

Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact 

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.